Revolution Medicines Overview
Revolution Medicines Target Price
Analysts' 12-month price predictions for RVMD.
Share Price
$38.95
Average Target Price
$73.50
88.7% upside
88.7% upside2 analysts in the last 4 months
High: $75 | Low: $72
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-08-19 | Piper SandlerKelsey Goodwin | $75 | 92.6% upside |  |
| 2025-05-14 | H.C. WainwrightRobert Burns | $72 | 84.9% upside | |
| 2025-04-01 | Stifel NicolausBenjamin Burnett | $64 | 64.3% upside | |
| 2025-01-08 | UBSEliana Merle | $71 | 82.3% upside | |
| 2024-11-07 | Piper SandlerJoseph Catanzaro | $70 | 79.7% upside | |
| 2024-11-04 | H.C. WainwrightRaghuram Selvaraju | $62 | 59.2% upside | |
| 2024-10-28 | GuggenheimMichael Schmidt | $82 | 110.5% upside | |
| 2024-10-28 | OppenheimerJay Olson | $60 | 54% upside | |
| 2024-10-15 | OppenheimerJay Olson | $55 | 41.2% upside | |
| 2024-09-17 | Piper SandlerJoseph Catanzaro | $57 | 46.3% upside | |
| 2024-08-08 | NeedhamAmi Fadia | $61 | 56.6% upside | |
| 2024-07-15 | WedbushRobert Driscoll | $59 | 51.5% upside | |
| 2024-04-19 | Stifel NicolausBen Burnett | $43 | 10.4% upside | |
| 2024-04-12 | NeedhamAmi Fadia | $46 | 18.1% upside | |
| 2024-04-12 | OppenheimerJay Olson | $45 | 15.5% upside | |
| 2024-04-10 | Raymond JamesLaura Prendergast | $48 | 23.2% upside | |
| 2023-11-16 | Raymond JamesDane Leone | $30 |  23% downside | |
| 2022-12-14 | Needham | $31 | 20.4% downside | |